In the relentless pursuit of transforming cancer therapeutics, Boundless Bio, a clinical-stage oncology company, is making waves with its groundbreaking research in extrachromosomal DNA (ecDNA). This San Diego-based biotech startup is dedicating its resources to address a critical unmet need in the oncology landscape – tackling the challenge of oncogene amplified tumors. Boundless Bio has […]